🔎 Trials Near Me

Home › Anemia › Texas › Houston

Anemia clinical trials in Houston, TX

5 studies for Anemia are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

RecruitingPhase 1/2
  • MD Anderson, Houston
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

RecruitingPhase 3
  • The University of Texas-MD Anderson Cancer Center - Leukemia Center, Houston
  • LUMI Research, Houston
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07422480

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

RecruitingPhase 3
  • MD Anderson Cancer Center, Houston
  • The University of Utah-Huntsman Cancer Institute, Houston
  • LUMI Research, Houston
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07623161

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

RecruitingPhase 3
  • U.T. MD Anderson Cancer Center, Division of Cancer Medicine, Houston
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT06499285

A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency

Recruiting
  • The University of Texas Health Science Center at Houston, Houston
Ages 18 and older · All sexes · Updated Dec 30, 2025 · NCT05735314

About Anemia

Anemia occurs when your blood doesn't carry enough oxygen to the rest of your body. Read about conditions that lead to it and treatments available.

More about Anemia on MedlinePlus

Anemia trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.